Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Germany”

Operating Room Black Box Supported Debriefings and Their Effect on Healthcare Professionals Effectiveness and Psychological Safety.Recruiting
NCT07396675NAUpdated Jul 23, 2026
Sponsor: ORNND - Operating Room Nurse Network Denmark
Stress · Resilience · Psychological Safety · Burnout, Healthcare Workers
Denmark, Germany, Netherlands
A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced MalignanciesRecruiting
NCT05957367Phase 1, Phase 2Updated Jul 23, 2026
Sponsor: Deciphera Pharmaceuticals, LLC
GIST
United States, Denmark, France, Germany, Italy +4 more
Intrahospital Influenza Vaccination in Patients at High Cardiovascular Risk (VACC-UP)Not Yet Recruiting
NCT07721649NAUpdated Jul 23, 2026
Sponsor: Stephan Baldus
Acute Coronary Syndrome · Heart Failure · Influenza, Human · Cardiovascular Diseases
Germany
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)Recruiting
NCT07202546Phase 2Updated Jul 23, 2026
Sponsor: ViiV Healthcare
HIV Infections
United States, Argentina, Australia, Belgium, Canada +9 more
Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo NodularisRecruiting
NCT07236099Phase 2Updated Jul 23, 2026
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Prurigo Nodularis (PN)
United States, China, Germany, Poland
A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast CancerActive Not Recruiting
NCT03975647Phase 3Updated Jul 23, 2026
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
HER2-positive Breast Cancer
United States, Australia, Austria, Belgium, Canada +15 more
Delirium and Cognitive Impairment Development in Hospitalized Older Adults Under Isolation ConditionsRecruiting
NCT07114458N/AUpdated Jul 23, 2026
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Delirium · Dementia · Cognitive Impairment
Germany
Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)®Terminated
NCT05900050Phase 2Updated Jul 23, 2026
Sponsor: Genfit
Acute-On-Chronic Liver Failure · Ascites
United States, Belgium, France, Germany, Hungary +2 more
A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent ChemoradiotherapyActive Not Recruiting
NCT04543617Phase 3Updated Jul 23, 2026
Sponsor: Hoffmann-La Roche
Esophageal Squamous Cell Carcinoma
United States, Argentina, Australia, Austria, Belgium +23 more
Selatogrel Outcome Study in Suspected Acute Myocardial InfarctionEnrolling By Invitation
NCT04957719Phase 3Updated Jul 23, 2026
Sponsor: Viatris Innovation GmbH
Acute Myocardial Infarction
United States, Australia, Austria, Belgium, Brazil +40 more
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine CancersRecruiting
NCT05882058Phase 2Updated Jul 23, 2026
Sponsor: Boehringer Ingelheim
Small Cell Lung Carcinoma · Neuroendocrine Neoplasms · Extra-pulmonary Neuroendocrine Carcinoma
United States, Belgium, Bulgaria, China, France +7 more
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint InhibitorRecruiting
NCT06472245Phase 3Updated Jul 23, 2026
Sponsor: OSE Immunotherapeutics
Patients With Non-Small Cell Lung Cancer
United States, Belgium, Canada, France, Germany +9 more
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative ColitisRecruiting
NCT05076175Phase 2, Phase 3Updated Jul 23, 2026
Sponsor: Bristol-Myers Squibb
Colitis, Ulcerative
United States, Australia, Belgium, Canada, France +8 more
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.Recruiting
NCT06916806Phase 1Updated Jul 23, 2026
Sponsor: AstraZeneca
Systemic Lupus Erythematosus · Idiopathic Inflammatory Myopathies · Rheumatoid Arthritis
United States, Canada, China, France, Germany +5 more
A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract CancerActive Not Recruiting
NCT02711553Phase 2Updated Jul 22, 2026
Sponsor: Eli Lilly and Company
Biliary Tract Cancer · Metastatic Cancer · Advanced Cancer
United States, Argentina, Australia, Austria, Belgium +13 more
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUCRecruiting
NCT07720284Phase 3Updated Jul 22, 2026
Sponsor: AstraZeneca
High-risk Muscle Invasive Urothelial Carcinoma
United States, Australia, Brazil, Canada, China +11 more
Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid TumorsActive Not Recruiting
NCT03485209Phase 2Updated Jul 22, 2026
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Colorectal Neoplasms · Carcinoma, Non-Small-Cell Lung · Exocrine Pancreatic Cancer · Carcinoma, Squamous Cell of Head and Neck
United States, Canada, France, Germany, Italy +2 more
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid TumorsActive Not Recruiting
NCT06157892Phase 2Updated Jul 22, 2026
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Breast Neoplasms · Gastroesophageal Junction Adenocarcinoma · HER2 Low Breast Neoplasms · HER2 Positive Breast Neoplasms
United States, Australia, Canada, Germany, Italy +5 more
A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple MyelomaActive Not Recruiting
NCT05083169Phase 3Updated Jul 22, 2026
Sponsor: Janssen Research & Development, LLC
Multiple Myeloma
United States, Argentina, Belgium, Brazil, Canada +16 more
A Study Evaluating APG777 in Atopic DermatitisActive Not Recruiting
NCT06395948Phase 2Updated Jul 22, 2026
Sponsor: Apogee Therapeutics, Inc.
Atopic Dermatitis
United States, Canada, Czechia, France, Germany +4 more
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have DiabetesRecruiting
NCT07284875Phase 3Updated Jul 22, 2026
Sponsor: Kailera
Obesity · Overweight
United States, Argentina, Australia, Bulgaria, Czechia +5 more
Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft SurgeryCompleted
NCT01294163Phase 3Updated Jul 22, 2026
Sponsor: Air Liquide Santé International
Coronary Artery Disease · General Anesthetic Drug Allergy · Coronary Artery Bypass Graft Surgery
France, Germany, Italy, Netherlands
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCLRecruiting
NCT06072131Phase 3Updated Jul 22, 2026
Sponsor: Acrotech Biopharma Inc.
Peripheral T Cell Lymphoma
United States, Canada, Germany, Hungary, Italy +5 more
Visual Performance of Patients Implanted With a Multifocal IOLCompleted
NCT06111222NAUpdated Jul 22, 2026
Sponsor: Carl Zeiss Meditec AG
Cataract · Refractive Lens Exchange
Germany, Spain
Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)Completed
NCT03924856Phase 3Updated Jul 22, 2026
Sponsor: Merck Sharp & Dohme LLC
Bladder Cancer
United States, Australia, Belgium, Canada, Denmark +17 more

Previous page Next page